Shanghai Hile Bio-Technology Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 118.71 million compared to CNY 156.98 million a year ago. Revenue was CNY 127.89 million compared to CNY 171 million a year ago.

Net income was CNY 44.68 million compared to CNY 30.27 million a year ago. Basic earnings per share from continuing operations was CNY 0.0694 compared to CNY 0.047 a year ago. Diluted earnings per share from continuing operations was CNY 0.0694 compared to CNY 0.047 a year ago.